ES2108189T3 - Factor estimulante de celulas b progenitoras. - Google Patents

Factor estimulante de celulas b progenitoras.

Info

Publication number
ES2108189T3
ES2108189T3 ES93118600T ES93118600T ES2108189T3 ES 2108189 T3 ES2108189 T3 ES 2108189T3 ES 93118600 T ES93118600 T ES 93118600T ES 93118600 T ES93118600 T ES 93118600T ES 2108189 T3 ES2108189 T3 ES 2108189T3
Authority
ES
Spain
Prior art keywords
cell
stimulating factor
progenitors
factor
progenating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93118600T
Other languages
English (en)
Inventor
Babru Bahan Samal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Application granted granted Critical
Publication of ES2108189T3 publication Critical patent/ES2108189T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

SE DESCRIBE UN FACTOR ESTIMULADOR DE UNA CELULA B PROGENITORA QUE ESTIMULA LA FORMACION DE CELULAS PRE-B. TAMBIEN SE PRESENTAN LAS SECUENCIAS DE ADN QUE LO CODIFICAN Y LOS METODOS PARA LA PRODUCCION Y PURIFICACION DEL FACTOR. EL FACTOR SE UTILIZA PARA EL TRATAMIENTO DE TRASTORNOS HEMATOPOYETICOS Y EN TRASPLANTES DE LA MEDULA OSEA.
ES93118600T 1992-11-20 1993-11-18 Factor estimulante de celulas b progenitoras. Expired - Lifetime ES2108189T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US98052492A 1992-11-20 1992-11-20

Publications (1)

Publication Number Publication Date
ES2108189T3 true ES2108189T3 (es) 1997-12-16

Family

ID=25527627

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93118600T Expired - Lifetime ES2108189T3 (es) 1992-11-20 1993-11-18 Factor estimulante de celulas b progenitoras.

Country Status (15)

Country Link
US (2) US5580754A (es)
EP (1) EP0601360B1 (es)
JP (1) JPH08505373A (es)
KR (1) KR950704356A (es)
CN (1) CN1094093A (es)
AT (1) ATE159545T1 (es)
AU (1) AU680851B2 (es)
CA (1) CA2149763A1 (es)
DE (1) DE69314754T2 (es)
DK (1) DK0601360T3 (es)
ES (1) ES2108189T3 (es)
GR (1) GR3025718T3 (es)
IL (1) IL107642A0 (es)
MX (1) MX9307229A (es)
WO (1) WO1994012535A1 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100387A (en) * 1997-02-28 2000-08-08 Genetics Institute, Inc. Chimeric polypeptides containing chemokine domains
US6852508B1 (en) * 1997-02-28 2005-02-08 Genetics Institute, Llc Chemokine with amino-terminal modifications
JP4689787B2 (ja) * 1999-04-12 2011-05-25 住友化学株式会社 腹腔内脂肪組織量の分析方法
ATE365326T1 (de) * 1999-04-12 2007-07-15 Sumitomo Chemical Co Verfahren zur analyse der menge an intraabdominalem fettgewebe
US8062675B2 (en) 1999-07-07 2011-11-22 Angioblast Systems, Inc. Mesenchymal precursor cell
AU2003901668A0 (en) 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
AUPQ147799A0 (en) * 1999-07-07 1999-07-29 Medvet Science Pty. Ltd. Mesenchymal precursor cell
AU2001271054A1 (en) * 2000-07-31 2002-02-13 Sumitomo Chemical Company Limited Method of analyzing accumulated fat content in adipocytes
AU2002227263A1 (en) * 2000-11-10 2002-05-21 Michigan State University A selectable genetic marker for use in pasteurellaceae species
US7977049B2 (en) * 2002-08-09 2011-07-12 President And Fellows Of Harvard College Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
US7488792B2 (en) * 2002-08-28 2009-02-10 Burnham Institute For Medical Research Collagen-binding molecules that selectively home to tumor vasculature and methods of using same
US20060025337A1 (en) * 2003-07-01 2006-02-02 President And Fellows Of Harvard College Sirtuin related therapeutics and diagnostics for neurodegenerative diseases
US20050096256A1 (en) * 2003-07-01 2005-05-05 President And Fellows Of Harvard College Compositions for manipulating the lifespan and stress response of cells and organisms
US7444419B2 (en) * 2003-10-10 2008-10-28 Microsoft Corporation Media stream scheduling for hiccup-free fast-channel-change in the presence of network chokepoints
US8017634B2 (en) 2003-12-29 2011-09-13 President And Fellows Of Harvard College Compositions for treating obesity and insulin resistance disorders
EP1708689A2 (en) * 2003-12-29 2006-10-11 The President and Fellows of Harvard College Compositions for treating or preventing obesity and insulin resistance disorders
JP2005213206A (ja) * 2004-01-30 2005-08-11 Iichiro Shimomura 糖代謝機能改善剤
US20060084085A1 (en) * 2004-06-16 2006-04-20 Sinclair David A Methods and compositions for modulating Bax-mediated apoptosis
CN101103101B (zh) * 2004-09-24 2012-10-10 成血管细胞系统公司 增强间充质前体细胞（mpc）的增生和/或存活的方法
AU2006204699B2 (en) * 2005-01-13 2012-04-26 Sirtris Pharmaceuticals, Inc. Novel compositions for preventing and treating neurodegenerative and blood coagulation disorders
WO2006138418A2 (en) * 2005-06-14 2006-12-28 President And Fellows Of Harvard College Improvement of cognitive performance with sirtuin activators
CN100457911C (zh) * 2006-01-24 2009-02-04 中国人民解放军第二军医大学 含有效b细胞活化因子基因启动子的重组质粒及其制备方法和用途
US8506933B2 (en) * 2007-11-30 2013-08-13 Msdx, Inc. Methods of detecting a neurological condition via analysis of circulating phagocytes
NZ600583A (en) * 2009-02-24 2013-08-30 Healor Ltd Visfatin therapeutic agents for the treatment of acne and other conditions
EP2504699A1 (en) * 2009-11-27 2012-10-03 MSDX, Inc. Methods of detecting or monitoring activity of an inflammatory or neurodegenerative condition
US8673309B2 (en) 2011-02-11 2014-03-18 Msdx, Inc. Methods for measuring high molecular weight complexes of fibrinogen with fibronectin and fibulin-1
KR20240138585A (ko) * 2023-03-08 2024-09-20 한양대학교 에리카산학협력단 Nampt 유래 펩타이드를 유효성분으로 포함하는 염증성 장 질환 개선, 예방 또는 치료용 조성물
CN117126756B (zh) * 2023-10-26 2024-03-12 中国科学院天津工业生物技术研究所 一种用于制备烟酰胺磷酸核糖基转移酶的重组菌株的构建方法及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179937A (en) * 1978-06-02 1979-12-25 Ocean Ecology Ltd. Sound measuring device
US4710473A (en) * 1983-08-10 1987-12-01 Amgen, Inc. DNA plasmids
JPS63500636A (ja) * 1985-08-23 1988-03-10 麒麟麦酒株式会社 多分化能性顆粒球コロニー刺激因子をコードするｄｎａ
US4935233A (en) * 1985-12-02 1990-06-19 G. D. Searle And Company Covalently linked polypeptide cell modulators
US5066581A (en) * 1987-02-25 1991-11-19 The Trustees Of Columbia University In The City Of New York Differentiation antigen, nda3, associated with the receptor for b cell growth factor
US4965195A (en) * 1987-10-26 1990-10-23 Immunex Corp. Interleukin-7
WO1989006541A1 (en) * 1988-01-14 1989-07-27 West Virginia University Dna sequences, recombinant dna molecules and processes for producing stromal derived lymphopoietic factor-1 polypeptides
HUT62011A (en) * 1989-10-16 1993-03-29 Amgen Inc Process for producing factors influencing the functioning of stem cells

Also Published As

Publication number Publication date
DE69314754D1 (de) 1997-11-27
EP0601360B1 (en) 1997-10-22
EP0601360A1 (en) 1994-06-15
AU5613594A (en) 1994-06-22
DE69314754T2 (de) 1998-02-19
MX9307229A (es) 1994-07-29
CN1094093A (zh) 1994-10-26
GR3025718T3 (en) 1998-03-31
DK0601360T3 (da) 1998-04-20
ATE159545T1 (de) 1997-11-15
CA2149763A1 (en) 1994-06-09
US5874399A (en) 1999-02-23
JPH08505373A (ja) 1996-06-11
KR950704356A (ko) 1995-11-20
AU680851B2 (en) 1997-08-14
IL107642A0 (en) 1994-02-27
US5580754A (en) 1996-12-03
WO1994012535A1 (en) 1994-06-09

Similar Documents

Publication Publication Date Title
MX9307229A (es) Factor de estimulacion de progenitores de celulas b, proceso para su obtencion y composiciones farmaceuticas que lo contienen.
IT8721618A0 (it) Prodecimento per la depurazione bilogica di acque reflue.
DE3873112D1 (de) Abwasserbehandlungsverfahren.
ES2134767T3 (es) Recombinacion locoespecifica de dna en celulas vegetales.
DE3886585D1 (de) Gesteuerte Hochfrequenzleistungsversorgung.
ATE90342T1 (de) 1-hydroxyvitamin d2-epimer und dessen derivate.
AR243605A1 (es) Un metodo para obtener protoporfirina ix del cultivo de microalgas eucarioticas del genero clamidomonas.
ATE64579T1 (de) Schwimmbadwasserbehandlung.
ES2022192B3 (es) Eteres de oximas sustituidos, su utilizacion como biorreguladores para la reduccion del nivel de etileno endogeno en las plantas.
FI102191B1 (fi) Menetelmä 3-des-hydroksikystatiini C:n tuottamiseksi ja menetelmässä käytettävä DNA-sekvenssi
HUP9802531A2 (hu) Eljárás haematopoeticus stem sejtek mobilizálására
BR8206304A (pt) Processo para operar um silo de mistura continua,bem como silo de mistura continua para aplicacao do processo
HUT41783A (en) Process for producing 12- and 13-bromo-ergoline derivatives
DK93390D0 (da) Ufuldstaendige hepadnavira og cellelinie, der producerer vacciner, samt behandling af leversygdomme og -forstyrrelser
FI872620A7 (fi) Menetelmä jätevesien biologiseksi puhdistamiseksi
IT8621057A0 (it) La produzione di prodotti sessuali impiego di sostanze stimolanti per da mammiferi,adatti per la fecondazione naturale ed artificiale e sostanze relative
FI851365A0 (fi) Liposomer med inhalerbara allergener foer behandling av allergener, foerfarande foer deras framstaellning och dessa innehaollande laekemedel.
ATE50792T1 (de) Herstellung von plasmid-dns und produkte davon.
AR016695A1 (es) Metodo para movilizar las celulas pluripotenciales hematopoyeticas
DE3885846D1 (de) Kontrollierte Stromquelle.
IT1201218B (it) Procedimento biologico di depurazione delle acque di rifiuto con zona di nitrificazione
IT8720050A0 (it) Procedimento per la depurazione di acque di rifiuto e per il trattamento dei fanghi.
IT8585615A0 (it) Apparecchio per la produzione continua di energia motrice.
ATE85893T1 (de) Verwendung von somatostatin zur herstellung eines arzneimittels fuer die behandlung von rheumatoider arthritis.
ENGLESSON et al. SYSTEM FOR TREATING SEWAGE WATER USING FLOCCULATION

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 601360

Country of ref document: ES